Neofect Co., Ltd. (KOSDAQ:290660)
696.00
+17.00 (2.50%)
At close: Jan 20, 2026
Neofect Revenue
Neofect had revenue of 3.37B KRW in the quarter ending September 30, 2025, a decrease of -5.28%. This brings the company's revenue in the last twelve months to 20.50B, up 9.65% year-over-year. In the year 2024, Neofect had annual revenue of 21.11B, down -20.67%.
Revenue (ttm)
20.50B
Revenue Growth
+9.65%
P/S Ratio
2.55
Revenue / Employee
359.61M
Employees
57
Market Cap
52.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 21.11B | -5.50B | -20.67% |
| Dec 31, 2023 | 26.61B | 412.30M | 1.57% |
| Dec 31, 2022 | 26.20B | 3.04B | 13.14% |
| Dec 31, 2021 | 23.16B | 4.53B | 24.34% |
| Dec 31, 2020 | 18.62B | 6.31B | 51.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Genoray | 102.75B |
| DRGEM | 98.34B |
| JPI Healthcare | 52.79B |
| CU Medical Systems | 44.79B |
| Hironic | 33.18B |
| Remed | 24.26B |
| MEKICS CO., | 11.70B |
| QuantaMatrix | 3.35B |